Pacific Shuanglin Bio-pharmacy Co., LTD reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 2,395.59 million compared to CNY 1,966.47 million a year ago. Revenue was CNY 2,405.19 million compared to CNY 1,971.73 million a year ago.

Net income was CNY 587.13 million compared to CNY 391.06 million a year ago. Basic earnings per share from continuing operations was CNY 0.8035 compared to CNY 0.5543 a year ago. Diluted earnings per share from continuing operations was CNY 0.8032 compared to CNY 0.553 a year ago.